Qian Jiang

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 42

Top Topics

Prognostic Factors

Chronic Myeloid Leukemia

Top Venues

British journal of haematology

American journal of hematology

Annals of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Li-Juan Hu, Guo-Mei Fu, Yuan-Yuan Zhang, Ya-Zhe Wang, Ya-Zhen Qin, Yue-Yun Lai, Hong-Xia Shi, Hao Jiang, Xiao-Hui Zhang, Lan-Ping Xu, Yu Wang, Qian Jiang, Xiao-Jun Huang, Ying-Jun Chang
Cytology or Multiparameter Flow Cytometry Positivity in the Cerebrospinal Fluid Before Transplantation is Predictive of Poor Outcomes After Allotransplantation in Acute Myeloid Leukemia Patients. Clinical transplantation 38 (7) (2024)
Yi Zhang, Hu Zhou, Zhongxing Jiang, Dengshu Wu, Junling Zhuang, Wei Li, Qian Jiang, Xiuli Wang, Jinwen Huang, Huan-Ling Zhu, Linhua Yang, Xin Du, Fei Li, Ruixiang Xia, Feng Zhang, Jian-da Hu, Yan Li, Han Yan, Jing Liu, Chenghao Jin, Kai Sun, Zeping Zhou, Liqing Wu, Hewen Yin, Shanshan Suo, Wenjuan Yu, Jie Jin
Efficacy, safety, and survival findings after long-term follow-up of ZGJAK002: A phase 2 study comparing jaktinib at 100 mg twice daily (BID) and 200 mg once daily (QD) in patients with myelofibrosis. American journal of hematology 99 (4) (2024)
Zongru Li, Xiaoshuai Zhang, Yijing Zhao, Linping Lu, Yong Guo, Robert Peter Gale, Yazhen Qin, Qian Jiang
Imatinib dose reduction after major molecular response in chronic-phase chronic myeloid leukemia. Cancer (2024)
Yi Zhang, Hu Zhou, Zhongxing Jiang, Dengshu Wu, Junling Zhuang, Wei Li, Qian Jiang, Xiuli Wang, Jinwen Huang, Huan-Ling Zhu, Linhua Yang, Xin Du, Fei Li, Ruixiang Xia, Feng Zhang, Jian-da Hu, Yan Li, Han Yan, Jing Liu, Chenghao Jin, Kai Sun, Zeping Zhou, Liqing Wu, Hewen Yin, Shanshan Suo, Wenjuan Yu, Jie Jin
Efficacy, safety, and survival findings after long-term follow-up of ZGJAK002: A phase 2 study comparing jaktinib at 100 mg twice daily (BID) and 200 mg once daily (QD) in patients with myelofibrosis. American journal of hematology (2024)
Yi Zhang, Hu Zhou, Zhongxing Jiang, Dengshu Wu, Junling Zhuang, Wei Li, Qian Jiang, Xiuli Wang, Jinwen Huang, Huan-Ling Zhu, Linhua Yang, Xin Du, Fei Li, Ruixiang Xia, Feng Zhang, Jian-da Hu, Yan Li, Han Yan, Jing Liu, Chenghao Jin, Kai Sun, Zeping Zhou, Liqing Wu, Hewen Yin, Shanshan Suo, Wenjuan Yu, Jie Jin
Efficacy, safety, and survival findings after long-term follow-up of ZGJAK002: A phase 2 study comparing jaktinib at 100 mg twice daily (BID) and 200 mg once daily (QD) in patients with myelofibrosis. American journal of hematology 99 (4) (2024)
Xiaoshuai Zhang, Bingcheng Liu, Jian Huang, Yanli Li Zhang, Na Xu, Robert Peter Gale, Weiming Li, Xiaoli Liu, Huanling Zhu, Ling Pan, Yunfan Yang, Hai Lin, Xin Du, Rong Liang, Chunyan Chen, Xiaodong Wang, Guohui Li, Zhougang Liu, Yanqing Zhang, Zhenfang Liu, Jianda Hu, Chunshui Liu, Fei Li, Wei Yang, Li Meng, Yanqiu Han, Li'e Lin, Zhenyu Zhao, Chuanqing Tu, Caifeng Zheng, Yanliang Bai, Zeping Zhou, Su-Ning Chen, Huiying Qiu, Lijie Yang, Xiuli Sun, Hui Sun, Li Zhou, Zelin Liu, Danyu Wang, Jianxin Guo, Liping Pang, Qingshu Zeng, Xiaohui Suo, Weihua Zhang, Yuanjun Zheng, Xiaojun Huang, Qian Jiang
A predictive model for therapy failure in chronic myeloid leukemia patients receiving tyrosine kinase inhibitor therapy. Blood (2024)
Fei-Fei Tang, Wen-Bing Duan, Xiao-Hong Liu, Sheng-Ye Lu, Xiao-Jun Huang, Ya-Zhen Qin, Jin-Song Jia, Jing Wang, Li-Zhong Gong, Qian Jiang, Ting Zhao, Hong-Xia Shi, Ying-Jun Chang, Xiao-Jun Huang, Hao Jiang
A complete oral regimen for induction therapy of patients with high-risk APL: An oral etoposide instead of intravenous infusion for cytoreductive chemotherapy. British journal of haematology 205 (2) (2024)
Robert Peter Gale, Qian Jiang, Jane F Apperley, Andreas Hochhaus
Is there really an accelerated phase of chronic myeloid leukaemia? Leukemia (2024)
Fei-Fei Tang, Wen-Bing Duan, Xiao-Hong Liu, Sheng-Ye Lu, Xiao-Jun Huang, Ya-Zhen Qin, Jin-Song Jia, Jing Wang, Li-Zhong Gong, Qian Jiang, Ting Zhao, Hong-Xia Shi, Ying-Jun Chang, Xiao-Jun Huang, Hao Jiang
A complete oral regimen for induction therapy of patients with high-risk APL: An oral etoposide instead of intravenous infusion for cytoreductive chemotherapy. British journal of haematology (2024)
Yi Zhang, Hu Zhou, Zhongxing Jiang, Dengshu Wu, Junling Zhuang, Wei Li, Qian Jiang, Xiuli Wang, Jinwen Huang, Huan-Ling Zhu, Linhua Yang, Xin Du, Fei Li, Ruixiang Xia, Feng Zhang, Jian-da Hu, Yan Li, Han Yan, Jing Liu, Chenghao Jin, Kai Sun, Zeping Zhou, Liqing Wu, Hewen Yin, Shanshan Suo, Wenjuan Yu, Jie Jin
Efficacy, safety, and survival findings after long-term follow-up of ZGJAK002: A phase 2 study comparing jaktinib at 100 mg twice daily (BID) and 200 mg once daily (QD) in patients with myelofibrosis. American journal of hematology 99 (4) (2024)
Sen Yang, Xiaoshuai Zhang, Robert Peter Gale, Xin Du, Chun-Yan Chen, Jian-Yu Weng, Jian Huang, Fei Li, Yun Zeng, Zhen Xiao, Jian-da Hu, Li-Jie Yang, Zhuo-Gang Liu, Guo-Hui Li, Xiu-Li Sun, Wei Yang, Ru Feng, Yan-Qiu Han, Yu Jing, Na Xu, Xiao-Li Liu, Zhen-Fang Liu, Xiao-Dong Wang, Shi-Xin Wu, Rong Liang, Yan-Li Zhang, Yun-Fan Yang, Huan-Ling Zhu, Ling Pan, Li Meng, Yan-Hong Zhao, Hai Yi, Yi-Lan Liu, Wei-Hua Zhang, Yuan-Jun Zheng, Ze-Ping Zhou, Su-Ning Chen, Hui-Ying Qiu, Wei-Ming Li, Zhi-Lin Jia, Yan-Liang Bai, Li-E Lin, Bing-Cheng Liu, Chun-Shui Liu, Jian-Min Luo, Jun-Xia Meng, Zhi-Qiang Sun, Yan-Qing Zhang, Xiao-Jun Huang, Qian Jiang
Imatinib compared with second-generation tyrosine kinase-inhibitors in persons with chronic myeloid leukemia presenting in accelerated phase. American journal of hematology (2023)
Wenbing Duan, Sen Yang, Ting Zhao, Lijuan Hu, Yazhen Qin, Jinsong Jia, Jing Wang, Shengye Lu, Hao Jiang, Xiaohui Zhang, Lanping Xu, Yu Wang, Yueyun Lai, Hongxia Shi, Xiaojun Huang, Qian Jiang
Comparison of efficacy between homoharringtonine, aclarubicin, cytarabine (HAA) and idarubicin, cytarabine (IA) regimens as induction therapy in patients with de novo core binding factor acute myeloid leukemia. Annals of hematology (2023)
Yu-Qian Sun, Xiao-Hui Zhang, Qian Jiang, Hao Jiang, Ying-Jun Chang, Yu Wang, Lan-Ping Xu, Kai-Yan Liu, Xiao-Jun Huang
Comparison of haploidentical hematopoietic stem cell transplantation with chemotherapy in older adults with acute myeloid leukemia. Bone marrow transplantation (2023)
Feiyang Qi, Xiao-Shuai Zhang, Robert Peter Gale, Bingcheng Liu, Jian Huang, Xiao-Jun Huang, Qian Jiang
External validation of the predictive scoring systems for molecular responses in chronic myeloid leukaemia receiving initial imatinib-therapy. Leukemia (2023)
Ya-Lan Zhou, Ming-Yue Zhao, Robert Peter Gale, Hao Jiang, Qian Jiang, Li-Xia Liu, Jia-Yue Qin, Shan-Bo Cao, Feng Lou, Lan-Ping Xu, Xiao-Hui Zhang, Xiao-Jun Huang, Guo Rui Ruan
Mutations in DEAD/H-box helicase 11 correlate with increased relapse risk in adults with acute myeloid leukaemia with normal cytogenetics. Leukemia (2023)
Xiao-Lu Zhu, Qian Jiang, Jin Lu, Yuqian Sun, Xiaosu Zhao, Shenmiao Yang, Fei-Fei Tang, Wenjing Yu, Ting Zhao, Xiaohong Liu, Jin-Song Jia, Wenbing Duan, Lijuan Hu, Jing Wang, Yang Liu, Nan Peng, Xuelin Dou, Rui Ma, Qiang Fu, Huifang Wang, Xin-Xin Liu, Xiao-Jun Huang, Hao Jiang
COVID-19 infection in patients with haematological malignancies: A single-centre survey in the latest Omicron wave in China. British journal of haematology (2023)
Xiao-Shuai Zhang, Robert Peter Gale, Bingcheng Liu, Jian Huang, Yanli Zhang, Xin Du, Jian-Yu Weng, Weiming Li, Na Xu, Xiaoli Liu, Chunyan Chen, Hai Lin, Guohui Li, Rong Liang, Zhuogang Liu, Xiaodong Wang, Yanqing Zhang, Yanqiu Han, Chunshui Liu, Jian-da Hu, Lie Lin, Wei Yang, Zhenfang Liu, Li Meng, Chuanqing Tu, Caifeng Zheng, Zeping Zhou, Yanliang Bai, Huiying Qiu, Suning Chen, Fei Li, Jianxin Guo, Zelin Liu, Hui Sun, Li Zhou, Ru Feng, Xiuli Sun, Xiao-Jun Huang, Qian Jiang
Validation of the imatinib-therapy failure model. Leukemia (2023)
Xiao-Lu Zhu, Qian Jiang, Jin Lu, Yuqian Sun, Xiaosu Zhao, Shenmiao Yang, Fei-Fei Tang, Wenjing Yu, Ting Zhao, Xiaohong Liu, Jin-Song Jia, Wenbing Duan, Lijuan Hu, Jing Wang, Yang Liu, Nan Peng, Xuelin Dou, Rui Ma, Qiang Fu, Huifang Wang, Xin-Xin Liu, Xiao-Jun Huang, Hao Jiang
COVID-19 infection in patients with haematological malignancies: A single-centre survey in the latest Omicron wave in China. British journal of haematology (2023)
Xiao-Lu Zhu, Qian Jiang, Jin Lu, Yuqian Sun, Xiaosu Zhao, Shenmiao Yang, Fei-Fei Tang, Wenjing Yu, Ting Zhao, Xiaohong Liu, Jin-Song Jia, Wenbing Duan, Lijuan Hu, Jing Wang, Yang Liu, Nan Peng, Xuelin Dou, Rui Ma, Qiang Fu, Huifang Wang, Xin-Xin Liu, Xiao-Jun Huang, Hao Jiang
COVID-19 infection in patients with haematological malignancies: A single-centre survey in the latest Omicron wave in China. British journal of haematology (2023)
Xin'an Pan, Yingjun Chang, Guo Rui Ruan, Fangfang Wei, Hao Jiang, Qian Jiang, Xiaojun Huang, Xiao-Jun Huang
Prognostic impact of FLT3-ITD mutation on NPM1 + acute myeloid leukaemia patients and related molecular mechanisms. British journal of haematology (2023)
Feiyang Qi, Mei Bao, Hanlin Gao, Xiaoshuai Zhang, Shasha Zhao, Chenglei Wang, Wenwen Li, Qian Jiang
Patients with chronic myeloid leukemia and coronavirus disease 2019 in the Omicron era. Annals of hematology (2023)
Xiao-Shuai Zhang, Robert Peter Gale, Zi-Yu Li, Meng-Yu Zhang, Xiao-Jun Huang, Qian Jiang
Predictive scoring systems for molecular responses in persons with chronic phase chronic myeloid leukemia receiving initial imatinib therapy. Leukemia 36 (8) (2022)
Sen Yang, Xiao-Shuai Zhang, Robert Peter Gale, Xiao-Jun Huang, Qian Jiang
Co-variates associated with outcomes of tyrosine kinase-inhibitor therapy in persons with chronic myeloid leukaemia initially presenting in accelerated phase. Leukemia 36 (7) (2022)
Yi Zhang, Hu Zhou, Zhongxing Jiang, Dengshu Wu, Junling Zhuang, Wei Li, Qian Jiang, Xiuli Wang, Jinwen Huang, Huan-Ling Zhu, Linhua Yang, Xin Du, Fei Li, Ruixiang Xia, Feng Zhang, Jian-da Hu, Yan Li, Han Yan, Jing Liu, Chenghao Jin, Kai Sun, Zeping Zhou, Liqing Wu, Wenjuan Yu, Jie Jin
Safety and efficacy of jaktinib in the treatment of Janus kinase inhibitor-naïve patients with myelofibrosis: Results of a phase II trial. American journal of hematology 97 (12) (2022)
Xiao-Shuai Zhang, Robert Peter Gale, Mei-Jie Zhang, Xiao-Jun Huang, Qian Jiang
A predictive scoring system for therapy-failure in persons with chronic myeloid leukemia receiving initial imatinib therapy. Leukemia 36 (5) (2022)
Fei-Fei Tang, Sheng-Ye Lu, Xiao-Su Zhao, Ya-Zhen Qin, Xiao-Hong Liu, Jin-Song Jia, Jing Wang, Li-Zhong Gong, Qian Jiang, Ting Zhao, Hong-Xia Shi, Ying-Jun Chang, Xiao-Jun Huang, Hao Jiang
PML-RARA transcript levels at the end of induction therapy are associated with prognosis in non-high-risk acute promyelocytic leukaemia with all-trans retinoic acid plus arsenic in front-line therapy: long-term follow-up of a single-centre cohort study. British journal of haematology 195 (5) (2021)
Fangyuan Zheng, Xuelin Dou, Liqiang Zhang, Jie Jin, Yanli Zhang, Bingcheng Liu, Li Meng, Xiaofan Zhu, Zesheng Lu, Yueping Jia, Huilan Liu, Hai Lin, Li Zhou, Xielan Zhao, Wei Yang, Hui Sun, Sixuan Qian, Hongxia Ma, Runhui Wu, Leping Zhang, Qian Jiang
Health-related quality of life in children with chronic myeloid leukemia in the chronic phase. Journal of cancer research and clinical oncology (2021)
Xuelin Dou, Fangyuan Zheng, Liqiang Zhang, Jie Jin, Yanli Zhang, Bingcheng Liu, Li Meng, Xiaofan Zhu, Zesheng Lu, Yueping Jia, Huilan Liu, Hai Lin, Li Zhou, Xielan Zhao, Wei Yang, Hui Sun, Sixuan Qian, Hongxia Ma, Xin Du, Qingxian Bai, Na Xu, Fanjun Meng, Zhilin Jia, Haixia Di, Leping Zhang, Qian Jiang
Adolescents experienced more treatment failure than children with chronic myeloid leukemia receiving imatinib as frontline therapy: a retrospective multicenter study. Annals of hematology 100 (9) (2021)
Lu Yu, Huifang Wang, Robert Peter Gale, Yazhen Qin, Yueyun Lai, Hongxia Shi, Xuelin Dou, Xiaojun Huang, Qian Jiang
Impact of socio-demographic co-variates on prognosis, tyrosine kinase-inhibitor use and outcomes in persons with newly-diagnosed chronic myeloid leukaemia. Journal of cancer research and clinical oncology (2021)
Xiao-Shuai Zhang, Robert Peter Gale, Xiao-Jun Huang, Qian Jiang
Is the Sokal or EUTOS long-term survival (ELTS) score a better predictor of responses and outcomes in persons with chronic myeloid leukemia receiving tyrosine-kinase inhibitors? Leukemia (2021)
Jing Wang, RunQing Lu, Ying Wu, JinSong Jia, Lizhong Gong, XiaoHong Liu, ShengYe Lu, Yu Wang, ChenHua Yan, Xin-Xin Liu, Xiao-Hui Zhang, Lan-Ping Xu, Qian Jiang, XiaoSu Zhao, HongXia Shi, YueYun Lai, XiaoJun Huang, Guo Rui Ruan, Hao Jiang
Detection of measurable residual disease may better predict outcomes than mutations based on next-generation sequencing in acute myeloid leukaemia with biallelic mutations of CEBPA. British journal of haematology 190 (4) (2020)
Jia-Min Zhang, Yan Xu, Robert P Gale, Li-Xin Wu, Jing Zhang, Yong-Huai Feng, Ya-Zhen Qin, Hao Jiang, Qian Jiang, Bin Jiang, Yan-Rong Liu, Yu-Hong Chen, Yu Wang, Xiao-Hui Zhang, Lan-Ping Xu, Xiao-Jun Huang, Xin-Xin Liu, Guo Rui Ruan
DPEP1 expression promotes proliferation and survival of leukaemia cells and correlates with relapse in adults with common B cell acute lymphoblastic leukaemia. British journal of haematology 190 (1) (2020)
Zongru Li, Yueyun Lai, Xiaohui Zhang, Lanping Xu, Kaiyan Liu, Yu Wang, Chenhua Yan, Hao Jiang, Xiaojun Huang, Qian Jiang
Monosomal karyotype is associated with poor outcomes in patients with Philadelphia chromosome-negative acute lymphoblastic leukemia receiving chemotherapy but not allogeneic hematopoietic stem cell transplantation. Annals of hematology 99 (8) (2020)
Ya-Lan Zhou, Li-Xin Wu, Robert Peter Gale, Zi-Long Wang, Jin-Lan Li, Hao Jiang, Qian Jiang, Bin Jiang, Shan-Bo Cao, Feng Lou, Ying Sun, Cheng-Cheng Wang, Yan-Rong Liu, Yu Wang, Ying-Jun Chang, Lan-Ping Xu, Xiao-Hui Zhang, Xin-Xin Liu, Guo Rui Ruan, Xiao-Jun Huang
Mutation topography and risk stratification for de novo acute myeloid leukaemia with normal cytogenetics and no nucleophosmin 1 (NPM1) mutation or Fms-like tyrosine kinase 3 internal tandem duplication (FLT3-ITD). British journal of haematology 190 (2) (2020)
Wen-Bing Duan, Xiaohong Liu, Jinsong Jia, Jing Wang, Lizhong Gong, Qian Jiang, Ting Zhao, Yu Wang, Xiaohui Zhang, Lanping Xu, Xiaosu Zhao, Yazhen Qin, Hongxia Shi, Yingjun Chang, Xiao-Jun Huang, Hao Jiang
The loss or absence of minimal residual disease of <0·1% at any time after two cycles of consolidation chemotherapy in CBFB-MYH11-positive acute myeloid leukaemia indicates poor prognosis. British journal of haematology 192 (2) (2020)
Lu Yang, Wen-Min Chen, Feng-Ting Dao, Yan-Huan Zhang, Ya-Zhe Wang, Yan Chang, Yan-Rong Liu, Qian Jiang, Xiao-Hui Zhang, Xin-Xin Liu, Xiao-Jun Huang, Ya-Zhen Qin
High aldehyde dehydrogenase activity at diagnosis predicts relapse in patients with t(8;21) acute myeloid leukemia. Cancer medicine 8 (12) (2019)
Jing Zhang, Wen-Yi Lu, Jia-Min Zhang, Run-Qing Lu, Li-Xin Wu, Ya-Zhen Qin, Yan-Rong Liu, Yue-Yun Lai, Hao Jiang, Qian Jiang, Bin Jiang, Lan-Ping Xu, Xiao-Hui Zhang, Xiao-Jun Huang, Guo-Rui Ruan, Xin-Xin Liu
S100A16 suppresses the growth and survival of leukaemia cells and correlates with relapse and relapse free survival in adults with Philadelphia chromosome-negative B-cell acute lymphoblastic leukaemia. British journal of haematology 185 (5) (2019)
Ya-Zhen Qin, Qian Jiang, Lan-Ping Xu, Hao Jiang, Yu Wang, Xiao-Su Zhao, Zong-Ru Li, Yue-Yun Lai, Yan-Rong Liu, Xiao-Hui Zhang, Kai-Yan Liu, Xiao-Jun Huang
The prognostic significance of Wilms' tumor gene 1 (WT1) expression at diagnosis in adults with Ph-negative B cell precursor acute lymphoblastic leukemia. Annals of hematology 98 (11) (2019)
Ya-Zhen Qin, Qian Jiang, Hao Jiang, Yue-Yun Lai, Hong-Xia Shi, Wen-Min Chen, Lu Yu, Xiao-Jun Huang
Prevalence and outcomes of uncommon BCR-ABL1 fusion transcripts in patients with chronic myeloid leukaemia: data from a single centre. British journal of haematology 182 (5) (2018)
Qian Jiang, Lu Yu, Robert Peter Gale
Patients' and hematologists' concerns regarding tyrosine kinase-inhibitor therapy in chronic myeloid leukemia. Journal of cancer research and clinical oncology 144 (4) (2018)
Lu Yu, Haibo Wang, Darko Milijkovic, Xiaojun Huang, Qian Jiang
Achieving optimal response at 12 months is associated with a better health-related quality of life in patients with chronic myeloid leukemia: a prospective, longitudinal, single center study. BMC cancer 18 (1) (2018)
Qian Jiang, Haibo Wang, Lu Yu, Robert Peter Gale
Higher out-of-pocket expenses for tyrosine kinase-inhibitor therapy is associated with worse health-related quality-of-life in persons with chronic myeloid leukemia. Journal of cancer research and clinical oncology 143 (12) (2017)